How to Treat SIRVA (Shoulder Injury Related to Vaccine)

Treatment for SIRVA typically starts conservatively with rest, anti-inflammatory medications, and ice, then escalates to corticosteroid injections or physical therapy if symptoms persist. Most people recover within one to three months with appropriate care, though a minority experience pain and restricted movement for much longer. Because SIRVA results from the vaccine being injected into or near the shoulder’s bursa or joint lining rather than into the deltoid muscle itself, the resulting inflammation can mimic several common shoulder conditions, and getting the right diagnosis early makes a real difference in how quickly you bounce back.

How SIRVA Differs From Normal Post-Vaccination Soreness

Almost everyone gets a sore arm after a shot. That tenderness peaks within a day or two and fades on its own. SIRVA is different. The pain starts within about 48 hours of the injection, is often severe, and does not improve on its typical post-shot timeline. You may notice sharp pain when lifting your arm overhead, difficulty reaching behind your back, or an aching that wakes you at night. SIRVA is thought to be an immune-mediated inflammatory response triggered when vaccine antigen is deposited into or near the subacromial bursa or synovial tissue instead of deep in the deltoid muscle.¹ That misplaced deposit sets off inflammation in structures that were never meant to receive the injection.

Physical examination usually reveals signs consistent with impingement and loss of range of motion, but there is no single exam finding unique to SIRVA.² That overlap with other shoulder conditions is why imaging often becomes necessary. MRI is the standard tool and commonly reveals subacromial bursitis, tendonitis, and adhesive capsulitis (frozen shoulder).³ In chronic cases that go undiagnosed for months, MRI may also show bone erosions of the greater tuberosity and bone marrow swelling.⁴ If your shoulder pain is significant and started right after a vaccination, an MRI can help confirm or rule out SIRVA and guide treatment decisions.

Conservative Treatment as the First Step

The initial approach for SIRVA is straightforward: rest, over-the-counter pain relief, and time. Non-steroidal anti-inflammatory drugs like ibuprofen or naproxen are the standard recommendation for managing both pain and inflammation. In published case reports, patients treated with NSAIDs and brief immobilization in a sling recovered a near-normal range of motion within about a month, with significant pain improvement along the way.⁵ Ice applied to the shoulder for 15 to 20 minutes several times a day can also help tamp down swelling in the early phase.

Treatment should be individually directed based on the severity of your symptoms. For mild cases, observation and local symptom management are the recommended starting point.⁶ The sling is worth mentioning carefully: brief use for a few days can reduce acute pain, but you do not want to immobilize the shoulder for too long. Prolonged immobilization increases the risk of adhesive capsulitis, where the shoulder joint capsule thickens and tightens, locking up your range of motion even further. Once the acute pain settles, gentle pendulum exercises and light stretching help maintain mobility while the inflammation resolves.

Corticosteroid Injections

When rest and NSAIDs are not enough, a corticosteroid injection into the subacromial space is the most commonly reported next step. In a case series of patients who received injections within five days of symptom onset, symptoms resolved completely within a month. For comparison, Centers for Disease Control and Prevention data has shown that about two-thirds of SIRVA patients experience pain lasting longer than a month, and roughly a quarter still have pain beyond three months.⁷ That contrast suggests early injection may shorten the recovery window considerably, though the evidence so far comes from small case series rather than large trials.

Corticosteroid injections are worth considering particularly if you cannot tolerate NSAIDs due to stomach issues, kidney concerns, or blood thinner use. The injection is typically ultrasound-guided to ensure the steroid reaches the inflamed bursa rather than surrounding tissue. Pain relief from a single injection can be dramatic, sometimes noticeable within days. If one injection provides partial relief but symptoms return, a second injection is sometimes offered after a few weeks, though repeated steroid injections carry their own risks to tendon integrity over time.

When MRI shows subacromial-subdeltoid bursitis specifically, a subacromial steroid injection tends to provide especially good relief.⁵ Your doctor may recommend the injection based on imaging findings even before conservative treatment has run its full course, particularly if your pain is severe and your daily functioning is significantly affected.

Physical Therapy and Rehabilitation

Physical therapy plays a critical role in SIRVA recovery, especially when adhesive capsulitis develops. Frozen shoulder is one of the more frustrating consequences of SIRVA because it compounds the original inflammation with progressive stiffness, creating a vicious cycle: pain discourages movement, and lack of movement tightens the joint capsule further. A structured physiotherapy program breaks that cycle through a combination of passive stretching, active range-of-motion exercises, and gradual strengthening.

In cases where adhesive capsulitis is the primary problem, patients treated with physiotherapy combined with hydrodilatation, a procedure where fluid is injected into the joint capsule to stretch it open, showed improvements in both pain scores and range of motion.⁸ Hydrodilatation is typically performed under imaging guidance and can be combined with a local anesthetic or steroid. The combination of physiotherapy plus hydrodilatation appears to be more effective than physiotherapy alone for frozen shoulder secondary to vaccination.

Even without frozen shoulder, physical therapy helps restore functional movement. Exercises generally progress from gentle pendulum swings and wall walks to resistance band work and overhead strengthening. The timeline varies, but most therapists plan a six-to-twelve-week program. You should be able to do your exercises at home between sessions, and consistency matters more than intensity in the early stages.

When Surgery Becomes Necessary

Surgery is rare for SIRVA and reserved for cases that do not respond to all the treatments described above. Recalcitrant cases, meaning those that fail to improve with months of conservative management, injections, and rehabilitation, may warrant surgical intervention.⁶ The type of surgery depends on the specific pathology. For persistent bursitis, an arthroscopic bursectomy can remove the inflamed bursa. For adhesive capsulitis that has not responded to hydrodilatation, arthroscopic capsular release can free up the joint. If the rotator cuff has been damaged, repair may be needed.

Nerve-related injuries follow a different trajectory. When SIRVA involves damage to the axillary or radial nerve from an injection placed too far from the correct site, nerve injuries resolve on a similar timeline to other SIRVA symptoms in some cases, but they more often require surgical intervention compared to soft-tissue injuries.⁹ Axillary and radial nerve damage has been documented as a consequence of incorrectly placed deltoid injections.¹⁰ Nerve injuries can present as weakness in lifting the arm, numbness over the outer shoulder, or difficulty with specific movements that the affected nerve controls.

What to Expect for Recovery

The honest answer is that recovery timelines vary widely. In a case series of 16 patients with SIRVA following COVID-19 vaccination, each patient recovered normal range of motion and most had only mild residual pain within three months, despite initially severe symptoms and imaging-confirmed shoulder pathology.¹¹ That is the encouraging picture. Some studies report a median time to symptom resolution of about 70 days.

But other reports are less optimistic. Residual pain and activity restriction have been documented lasting for years in some individuals.⁹ Notably, in cases where no treatment was pursued, symptoms have persisted for up to 15 months. That underscores why seeking medical attention early matters. One case report documented ongoing pain, restricted shoulder movement, and disability more than two years post-injury.¹² These long-term cases are the exception rather than the rule, but they are real, and they tend to involve either delayed diagnosis, inadequate treatment, or underlying pathology such as nerve injury or severe adhesive capsulitis.

The type of vaccine does not appear to predict how bad SIRVA will be or how long it lasts. No clear correlation has been found between a specific vaccine type and symptom severity or duration.² SIRVA has been reported with flu shots, COVID-19 vaccines, tetanus boosters, and others. The common factor is injection technique, not the vaccine itself.

Who Is at Higher Risk

Certain people appear more vulnerable to SIRVA. Systematic reviews have found that SIRVA is more prevalent in women and in individuals with higher body mass index.³ For women, shorter deltoid muscles and thinner subcutaneous tissue may mean the needle is more likely to overshoot the muscle and reach the bursa. For people with higher BMI, the picture is more complicated: extra subcutaneous fat can paradoxically mean the vaccine ends up too shallow in some cases, or the vaccinator may use a longer needle that overshoots in others.

People with smaller frames, less deltoid muscle mass, or pre-existing shoulder conditions are also likely at elevated risk, though formal studies quantifying these individual factors are limited. Pediatric and adolescent patients present their own challenges because deltoid muscle size varies enormously in growing children, making standardized injection depth unreliable.¹³

How SIRVA Can Be Prevented

Since SIRVA is fundamentally an injection-technique problem, prevention comes down to placing the needle in the right spot at the right depth. Research on optimal injection site has found that the ideal location for adult immunization is about 4 centimeters below and in line with the back-outside corner of the acromion, the bony point at the top of your shoulder. That site is actually more posterior and lower than what current CDC guidelines recommend.¹⁴ The same research cautioned against using a 1.5-inch needle for patients weighing under about 118 kilograms because of the high predicted rate of overpenetration, meaning the needle goes all the way through the muscle and into the structures beneath it.

Training matters. Mixed-reality anatomy tools used in pharmacy education have helped students visualize exactly why correct placement matters: injections given too low can hit the radial nerve, while those given too far to the side can damage the axillary nerve.¹⁵ As a patient, you can reduce your own risk by wearing a shirt that allows full exposure of the shoulder rather than simply pulling a tight sleeve up. When the vaccinator can see the acromion and the full deltoid, they can landmark accurately. Sitting upright with your arm relaxed at your side, rather than propping your hand on your hip, also helps the vaccinator target the thickest part of the deltoid.

Emerging Treatments and Research Gaps

Because SIRVA largely involves the same structures affected by other shoulder injuries, treatments used for non-SIRVA shoulder conditions sometimes get applied here. Platelet-rich plasma (PRP) therapy, where concentrated platelets from your own blood are injected into the shoulder, has been recommended for adhesive capsulitis and medium-to-large rotator cuff repairs in broader shoulder research. However, PRP is not recommended for subacromial impingement, and there is insufficient evidence to include it in treatment protocols for most other shoulder disorders.¹⁶ Since subacromial bursitis is the most common finding in SIRVA, PRP’s role here is limited at best. If your SIRVA has progressed to adhesive capsulitis that has not responded to standard therapies, PRP is at least worth a conversation with your orthopedist, but it is not a standard part of the SIRVA treatment ladder.

The evidence base for SIRVA treatment overall remains thin. Most of what we know comes from case reports and small case series rather than randomized controlled trials. No one has conducted a head-to-head comparison of early corticosteroid injection versus watchful waiting, for example, or tested whether starting physical therapy immediately improves outcomes compared to a wait-and-see approach. That is partly because SIRVA is uncommon enough that assembling a large study group is difficult. For now, treatment is guided by clinical experience and by analogy with other shoulder inflammatory conditions.

The Vaccine Injury Compensation Program

In the United States, SIRVA is a recognized injury under the National Vaccine Injury Compensation Program (VICP). The VICP maintains a table of injuries associated with specific vaccines, and SIRVA has been included on this table for vaccines administered to the shoulder, meaning that if your symptoms begin within 48 hours of vaccination and last at least six months, you may qualify for compensation without having to prove fault. An analysis of VICP claims between 2010 and 2016 examined medical reports of alleged SIRVA and SIRVA-like injuries submitted to the program.¹⁷ SIRVA claims rose substantially during that period, and the program has continued to process them since.

Filing a VICP claim requires documentation including medical records showing onset of symptoms after vaccination, imaging results, and treatment records. Having an MRI that confirms bursitis, tendonitis, or another SIRVA-associated finding strengthens a claim considerably.¹⁸ The program covers medical expenses, lost wages, and pain and suffering. Claims must generally be filed within three years of symptom onset. An attorney experienced with vaccine injury cases can help navigate the process, and attorney fees are typically covered by the program even if the claim is denied. If you are dealing with SIRVA that has significantly disrupted your life, this is a resource worth exploring.